Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andreeff

Showing results (91-100 of 315) with videos related to

Pageof 32
Sort By:
Blood|May 15, 1995
Decreased expression of the deleted in colorectal carcinoma gene in non-Hodgkin's lymphomaA Younes, S Zhao, D Jendiroba, et al.
Experimental Hematology|October 1, 1981
Detection of luxol-fast-blue positive cells in human promyelocytic leukemia cell line HL-60L Lu, H E Broxmeyer, L M Pelus, et al.
Biotechniques|October 1, 1996
Semi-automated PCR method for quantitating MDR1 expressionS Zhao, U Consoli, R Arceci, et al.
Haematology and Blood Transfusion|January 1, 1987
Prognostic factors in acute lymphoblastic leukemia in adults: the Memorial Hospital experienceM Andreeff, J Gaynor, D Chapman, et al.
Blood|June 15, 1995
The PML gene encodes a phosphoprotein associated with the nuclear matrixK S Chang, Y H Fan, M Andreeff, et al.
Hematology and Cell Therapy|April 1, 1997
Expression of CD95(FAS) by gene transfer does not sensitize K562 to Fas-killingR Munker, F Marini, S Jiang, et al.
Leukemia Research|October 23, 1998
Further characterization of cyclophosphamide resistance: expression of CD95 and of bcl-2 in a CML cell lineR Munker, S Zhao, S Jiang, et al.
Annals of Internal Medicine|April 1, 1983
Acute non-lymphoblastic leukemia after treatment of nodular lymphoma with human leukocyte interferonR P Warrell, S E Krown, B Koziner, et al.
Onkologie|August 1, 1983
[Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity]W Hiddemann, T Büchner, M Andreeff, et al.
Blood|February 15, 1991
Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotypeE Berman, M Adams, R Duigou-Osterndorf, et al.
Pageof 32

Showing results (91-100 of 315) with videos related to

Sort By:
Pageof 32
Blood|May 15, 1995
Decreased expression of the deleted in colorectal carcinoma gene in non-Hodgkin's lymphomaA Younes, S Zhao, D Jendiroba, et al.
Experimental Hematology|October 1, 1981
Detection of luxol-fast-blue positive cells in human promyelocytic leukemia cell line HL-60L Lu, H E Broxmeyer, L M Pelus, et al.
Biotechniques|October 1, 1996
Semi-automated PCR method for quantitating MDR1 expressionS Zhao, U Consoli, R Arceci, et al.
Haematology and Blood Transfusion|January 1, 1987
Prognostic factors in acute lymphoblastic leukemia in adults: the Memorial Hospital experienceM Andreeff, J Gaynor, D Chapman, et al.
Blood|June 15, 1995
The PML gene encodes a phosphoprotein associated with the nuclear matrixK S Chang, Y H Fan, M Andreeff, et al.
Hematology and Cell Therapy|April 1, 1997
Expression of CD95(FAS) by gene transfer does not sensitize K562 to Fas-killingR Munker, F Marini, S Jiang, et al.
Leukemia Research|October 23, 1998
Further characterization of cyclophosphamide resistance: expression of CD95 and of bcl-2 in a CML cell lineR Munker, S Zhao, S Jiang, et al.
Annals of Internal Medicine|April 1, 1983
Acute non-lymphoblastic leukemia after treatment of nodular lymphoma with human leukocyte interferonR P Warrell, S E Krown, B Koziner, et al.
Onkologie|August 1, 1983
[Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity]W Hiddemann, T Büchner, M Andreeff, et al.
Blood|February 15, 1991
Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotypeE Berman, M Adams, R Duigou-Osterndorf, et al.
Pageof 32